Investor Presentaiton

Well-defined growth strategy The acquisition of Medlab forms part of a well-defined strategic growth plan Strategic Acquisitions Organic Market Growth . Non-COVID pathology market forecast to grow ~4% to 6% p.a. (1) due to predictable and consistent drivers including growing and ageing population, increasing testing rates and scientific and technological advancements Embedded Revenue Opportunities • Broaden general practitioner relationships GOT Precision medicine SunDoctors • Ramp up existing contracts • Increased clinical trial revenue . Commercial and other COVID testing Operational Performance Improvements Continuous improvement program . Extract additional . benefits from unified pathology system Opportunities from SunDoctors integration • National connectivity drives best practice Footprint Expansion Increase position in New South Wales growth corridors • Targeted revenue growth in Queensland Provide additional services • Acquisitions in specialist and general pathology (1) Partners in Performance estimates. Previous investment provides strong foundations for future growth 10

View entire presentation